North Star Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-56,550
Closed -$1.16M – 1189
2021
Q4
$1.16M Hold
56,550
– – 0.08% 212
2021
Q3
$1.22M Sell
56,550
-275
-0.5% -$6.62K 0.1% 196
2021
Q2
$1.64M Buy
56,825
+900
+2% +$24.3K 0.13% 168
2021
Q1
$1.36M Buy
+55,925
New +$1.26M 0.13% 169

Other funds holding PAHC

North Star Investment Management's PAHC Position: Q1 2022 in Review

North Star Investment Management sold out of Phibro Animal Health (PAHC) in Q1 2022, closing a stake of 56,550 shares — an estimated $1.16M sold.

North Star Investment Management first reported a position in PAHC in Q1 2021 and held it in 4 quarters. The position peaked at $1.64M in Q2 2021. 153 funds tracked by Wall St. Rank hold PAHC as of Q1 2022.

  • North Star Investment Management reported no remaining Phibro Animal Health position as of Q1 2022 after selling out during the quarter.
  • North Star Investment Management sold 56,550 Phibro Animal Health shares in Q1 2022, an estimated $1.16M.
  • North Star Investment Management first reported a position in Phibro Animal Health in Q1 2021 and held it in 4 quarters.
  • North Star Investment Management's Phibro Animal Health position peaked at $1.64M in Q2 2021.
  • 153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2022.

Based on North Star Investment Management's 13F filing for Q1 2022, filed 3 May 2022.